CONSTRAINT-INDUCED MOVEMENT THERAPY VERSUS CROSS EDUCATION IN CHILDREN WITH CEREBRAL PALSY (NEUROLOGY)

November 25, 2024 updated by: Abdullah Owaid Kerdi Alanazi, Imam Abdulrahman Bin Faisal University

Lower Limb Constraint-induced Movement Training Versus Strength Training of the Non-hemiplegic Lower Limb on Motor Performance in Children With Hemiplegic Cerebral Palsy: A Randomized Control Trial.

This clinical trial aims to Compare the effectiveness of lower limb CIMT and the Strength Training of the Non-Hemiplegic lower limb on motor performance in hemiplegic children with CP.

Participants will:

diagnosed with hemiplegic cerebral palsy treated with CIMT or Strength training (cross-education) for a non-hemiplegic limb for 8 weeks.

3 sessions per week. Measurements will be taken at baseline and then at the end of the 8 weeks.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Method:

32 children with hemiplegic CP will be equally and randomly allocated to two groups (group A and B). group A will receive lower limb CIMT for the non- hemiplegic limb using whole leg orthosis and Group B will receive strengthen training for the non-hemiplegic lower limb. Both groups will receive routine physical therapy for the hemiplegic lower limb. Both groups will receive 60 minutes training session for 3 sessions per week for 8 consecutive weeks. Assessment will be at baseline then at the end of trial.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Dammam, Saudi Arabia
        • Imam Abdulrahmn Alfaisal University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Children with hemiplegic cerebral palsy aged age between 4 and 10.
  2. (GMFCS) levels I, II and III.
  3. Able to follow therapist instructions during training session.

Exclusion Criteria:

  1. Lack of patient's cooperation.
  2. Difficulty wearing constraint method due to severe joint deformation or/and contracture.
  3. Patients were treated with botulinum toxin during the last 3 months.
  4. Seizure disorder not fully controlled by medication.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CIMT GROUP
children in the CIMT group will RECIEVE lower limb CIMT for the non-hemiplegic limb using whole leg orthosis. Children in cross-education group will receive strengthening training for the non-hemiplegic lower limb
Experimental: STRENGHTH TRAINING GROUP (cross education)
children in the CIMT group will RECIEVE lower limb CIMT for the non-hemiplegic limb using whole leg orthosis. Children in cross-education group will receive strengthening training for the non-hemiplegic lower limb

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gait speed
Time Frame: at base line then at the end of the 8 weeks
gait spatiotemporal parameter
at base line then at the end of the 8 weeks
cadence gait spatiotemporal parameter
Time Frame: at base line then at the end of the 8 weeks
gait spatiotemporal parameter
at base line then at the end of the 8 weeks
step length
Time Frame: at base line then at the end of the 8 weeks
gait spatiotemporal parameter
at base line then at the end of the 8 weeks
stride length
Time Frame: at base line then at the end of the 8 weeks
gait spatiotemporal parameter
at base line then at the end of the 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pediatric balance scale
Time Frame: at base line then at the end of the 8 weeks
Pediatric balance scale The Pediatric Balance Scale is a modified version of the Berg Balance Scale that is used to assess functional balance skills in school-aged children. The scale consists of 14 items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56 points.
at base line then at the end of the 8 weeks
6 Minute walk test (6MWT)
Time Frame: at base line then at the end of the 8 weeks
endurance measurement
at base line then at the end of the 8 weeks
Modified Ashworth scale
Time Frame: at base line then at the end of the 8 weeks

measuring muscle tone Scoring 0 No Increased in tone

  1. Slight increase in tone giving a catch when the limb is moved in flexion or extension 1+ Slight increase in muscle tone, indicated by a catch followed by minimal resistance throughout range of motion (ROM)
  2. More marked increase in tone through most of the ROM, but the limb easily flexed
  3. Considerable increase in tone, passive movement difficult
  4. Limb rigid in flexion or extension
at base line then at the end of the 8 weeks
Handheld dynamometer
Time Frame: at base line then at the end of the 8 weeks
measuring muscles strength
at base line then at the end of the 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 30, 2024

Primary Completion (Estimated)

February 28, 2025

Study Completion (Estimated)

April 29, 2025

Study Registration Dates

First Submitted

September 9, 2024

First Submitted That Met QC Criteria

November 25, 2024

First Posted (Estimated)

November 26, 2024

Study Record Updates

Last Update Posted (Estimated)

November 26, 2024

Last Update Submitted That Met QC Criteria

November 25, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-PGS-2024-03-156

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiplegic Cerebral Palsy

Clinical Trials on rehabilitation

Subscribe